Process for preparing antiviral compounds
AssigneeAbbVie Inc.
InventorsShashank Shekhar, Thaddeus S. Franczyk, David M. Barnes, Travis B. Dunn, Anthony R. Haight, Vincent S. Chan
Life of this patent
Estimating the term…
Abstract
This disclosure is directed to: (a) processes for preparing compounds and salts thereof that, inter alia, are useful for inhibiting hepatitis C virus (HCV); (b) intermediates useful for the preparation of the compounds and salts; (c) pharmaceutical compositions comprising the compounds or salts; and (d) methods of use of such compositions.
Claims3
A composition comprising a compound, or salt thereof, wherein the compound has a structure corresponding to formula (4a):
- and
- N-(6-(3-tert-butyl-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-2-methoxyphenypnaphthalen-2-yl)methanesulfonamide (compound (A-1)) or a salt thereof.
A composition comprising 1-(3-tert-butyl-5-(6-hydroxynaphthalen-2-yl)-4-methoxyphenyl)pyrimidine-2,4(1H,3H)-dione compound (4a)) and N-(6-(3-tert-butyl-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-2-methoxyphenyl)naphthalen-2-yl)methanesulfonamide (compound (A-1)) or a salt thereof.
A composition comprising a compound, or salt thereof, wherein the compound has a structure corresponding to formula (4a):
- and
- N-(6-(3-tert-butyl-5-(2,4-dihydropyrimidin-1(2H)-yl)-2-methoxyphenyl)naphthalen-2-yl)methanesulfonamide sodium salt.
Dependencies are inferred from the claim text.